Literature DB >> 19085686

Reconstruction of head and neck cancer with double flaps: comparison of single and double recipient vessels.

Pao-Yuan Lin1, Yur-Ren Kuo, Chih-Yen Chien, Seng-Feng Jeng.   

Abstract

Patients with advanced head and neck cancers require reconstruction with a double free flap, but in some situations, it is extremely difficult to attain the ideal set of recipient vessels for these patients. The patients were divided into two groups: group 1 had one recipient vessel; group 2 had two recipient vessels. Fifty-five patients were enrolled between 2001 and 2005. Double flaps, including a fibula osteoseptocutaneous flap and an anterolateral thigh flap, were used for the reconstruction. In group 1, the second flap was anastomosed at the distal runoff of the fibular flap. Group 1 contained 39 patients and group 2 had 16 patients. No significant differences in the success rate, operating time, days of hospitalization, or complication rate were noted between groups 1 and 2. Thus using one recipient vessel is our first choice for double free-flap reconstruction for head and neck defects.

Entities:  

Mesh:

Year:  2008        PMID: 19085686     DOI: 10.1055/s-0028-1103508

Source DB:  PubMed          Journal:  J Reconstr Microsurg        ISSN: 0743-684X            Impact factor:   2.873


  3 in total

Review 1.  Head and Neck Reconstruction of the Vessel-Depleted Neck: A Systematic Review of the Literature.

Authors:  Beatriz Hatsue Kushida-Contreras; Oscar J Manrique; Miguel Angel Gaxiola-García
Journal:  Ann Surg Oncol       Date:  2021-02-06       Impact factor: 5.344

2.  Reconstruction for Complex Oromandibular Facial Defects: The Fibula Free Flap and Pectoralis Major Flap Combination.

Authors:  Mohammed Qaisi; Ryan Dee; Issam Eid; James Murphy; Ignacio A Velasco Martinez; Henry Fung
Journal:  Case Rep Surg       Date:  2019-03-26

3.  Oromandibular reconstruction: the history, operative options and strategies, and our experience.

Authors:  Pao-Yuan Lin; Kevin C Lin; Seng-Feng Jeng
Journal:  ISRN Surg       Date:  2011-12-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.